Name: B12 and B-Complex: Who Actually Needs It, and the B6 Trap
Creator: Realised
Published: 2026-06-01

Summary

B12 is a genuine, sometimes urgent fix for a defined set of risk groups (vegans, adults over 50, long-term metformin or acid-suppressant users, pernicious anaemia, post-GI-surgery) — but in most of those people the cause is malabsorption, not low dietary intake, so eating more meat won't fix it and a cheap cyanocobalamin supplement will; meanwhile "B vitamins for energy" sold to the already-replete is empty marketing, and the high-dose B6 baked into many B-complex and "energy" products is a real, under-publicised nerve-damage hazard.

Why Strong

Tier 1 because: the risk-group gating is NIH ODS / Food & Nutrition Board consensus; the "no benefit in the replete" finding rests on a 16-RCT meta-analysis plus a dedicated fatigue RCT; the cyanocobalamin = methylcobalamin (oral) equivalence is supported across reviews; and the B6 neurotoxicity ceiling is established physiology backed by EFSA and two national regulators.

NOT Tier 0.5 because it involves practical judgement (which risk group, test-before-treat, dose) and a genuine two-sided commercial controversy, not a single undisputed axiom.
NOT Tier 2 because the core claims are replicated trials plus consensus and regulatory guidance, not "a few suggestive studies" — only the methylcobalamin-for-neuropathy exception sits lower, and the entry treats it as such.

Practical takeaway

The gate first — who actually benefits:
• Vegans / strict vegetarians: supplementation is non-negotiable (no B12 in unfortified plant food).
• Adults over 50: get most B12 from fortified food or a supplement, not ordinary diet (food-bound malabsorption).
• Long-term metformin and chronic PPI/H2-blocker users: periodic serum B12 (± MMA) check; supplement if low.
• Pernicious anaemia / post-GI-surgery / malabsorption: high-dose oral or IM injection, clinically managed.

Dose: RDA is 2.4 mcg/day. Oral repletion of dietary or drug-induced low B12 is typically 250–1000 mcg/day (passive diffusion covers ~1% of an oral dose, enough at these intakes). Pernicious anaemia: 1000 mcg/day oral or IM per clinician.

Form: cyanocobalamin — cheapest and equally effective orally. Don't pay the premium for methylcobalamin.

Test before treating fatigue with B12. A serum B12 (ideally with MMA or holotranscobalamin if borderline) tells you whether deficiency is even the cause before you spend months on a supplement that does nothing for a replete person. See fatigue_cross_pillar_diagnostic — fatigue has many causes and B12 is only one.

Who should NOT bother, and who should be cautious:
• Replete adults with a normal diet and no risk factor get no energy or cognition benefit — skip it.
• Avoid B-complex or "energy" products carrying >12 mg of B6, and never stack multiple B6-containing products. Read the label for the pyridoxine figure specifically (the same label-literacy discipline as supplement_form_elemental_dose_and_bioavailability).
• Anyone on long-term high-dose B6 who develops numbness or tingling should stop and get checked — sensory neuropathy can be irreversible if use continues.

Evidence detail

Why This Entry Exists

"B vitamins for energy" is one of the most successful supplement stories ever told. It sells B12 shots to tired-but-replete people, premium "methylated/natural" B12 to anyone who reads a wellness blog, and high-dose B-complexes to the mass market on a vague stimulant promise that the biochemistry does not support. At the same time, a contrarian counter-story ("just eat liver and meat, supplements are a scam") gets the actual mechanism wrong for the majority of deficient people, whose problem is that they can't absorb the B12 in food no matter how much they eat.

This entry exists to gate B12 to the people who genuinely benefit, to correct the dominant mechanism (malabsorption, not diet), to settle the form question (cyanocobalamin is fine and cheapest), and to flag the one place the "B-vitamins-are-harmless-water-soluble" assumption is dangerously wrong: B6 neurotoxicity at the doses commonly hidden inside B-complex tablets.

What bad advice this protects against, in both directions:
• "B12/B-complex will give me energy" (the supplement-marketing pole) → for a replete person with a normal diet, it does nothing; B12 only relieves fatigue caused by deficiency. You pay for a non-effect.
• "Buy the methylated/natural form, it's superior" → for oral repletion there is no head-to-head clinical advantage over plain cyanocobalamin, which is cheaper and more stable.
• "Just eat more meat/liver, you don't need a pill" (the contrarian pole) → wrong for the malabsorption-driven majority — atrophic gastritis, metformin, PPIs, lost intrinsic factor — where dietary B12 can't be liberated or absorbed and a supplement (or injection) is the only fix.
• "B-complex is water-soluble so more is harmless" → false for B6; high-dose pyridoxine causes dose-dependent sensory peripheral neuropathy, sometimes irreversible.

It does not own the general "should I take a multivitamin / supplement at all" question (universal_nearuniversal_supplementation) or the testing logic for deficiencies broadly (micronutrient_deficiency_screening); it owns the B12 risk-group case, the form answer, and the B6 hazard.

Evidence

1. The risk-group gating is real and evidence-based (Tier 1). The NIH Office of Dietary Supplements and the Food & Nutrition Board name the groups who actually need B12 attention: vegans and strict vegetarians (there is no B12 in unfortified plant food), adults over 50, long-term metformin users, chronic PPI/H2-blocker users, people with pernicious anaemia, and those with GI surgery or malabsorption (Crohn's, Roux-en-Y). Deficiency runs at roughly 3–43% of older adults depending on cutoff and population. This is not a "everyone is deficient" panic — it is a bounded list, and that bounding is the point.

2. Malabsorption, not low intake, is the dominant mechanism outside vegans (Tier 1). Food-bound B12 needs stomach acid to be liberated before intrinsic factor can carry it across the gut. Atrophic gastritis affects 10–30% of older adults, reducing that acid — so the Food & Nutrition Board explicitly advises adults over 50 to get most of their 2.4 mcg/day RDA from fortified food or supplements rather than ordinary diet. The implication is counter-intuitive and load-bearing: eating more meat or eggs often won't fix it, because crystalline B12 in a supplement is absorbed even when food-bound B12 is not. Pernicious anaemia (autoimmune loss of intrinsic factor) needs high-dose oral or injected B12 regardless of diet.

3. Drug-induced depletion is quantified (Tier 1–2). Long-term metformin lowers serum B12 by roughly 19% on average, with deficiency up to ~30% in elderly diabetics. Chronic PPI use beyond two years is associated with a ~65% increased deficiency risk, and combined metformin + PPI compounds it (Jung et al., 2025, Journal of Diabetes Investigation; corroborated by a 2025 MDPI Diseases disproportionality analysis). These are common, often-invisible drug effects in exactly the populations least likely to be screened.

4. Form does NOT matter for oral correction (Tier 1). Multiple reviews find no consistent evidence that methylcobalamin beats cyanocobalamin for oral bioavailability, biochemical effect, or clinical efficacy. Cyanocobalamin is the cheap, stable, standard-of-care form. The "methylated/natural is superior" claim is a marketing premium, not a clinical finding. (Narrow, weak Tier 3 exception: methyl-/methylcobalamin studied for diabetic peripheral neuropathy — a specific clinical use, not general repletion.)

5. "B12/B-complex for energy or mood" fails in the replete (Tier 1). A systematic review and meta-analysis of 16 RCTs, 6,276 participants found no effect of B12 or B-complex on any cognitive subdomain (effect sizes 0.03–0.06, confidence intervals crossing zero) and no effect on depressive symptoms (−0.05) in people without overt deficiency (Markun et al., 2021, Nutrients). A double-blind RCT of 1000 µg/day B12 for 8 weeks in fatigued IBS/IBD patients with normal B12 (≥150 pmol/L) showed no benefit on fatigue, depression, or quality of life (Tan et al.). The correction is precise: B12 relieves fatigue caused by deficiency; it is not a stimulant or an energy supplement.

6. High-dose B6 is a genuine neurotoxicity hazard (Tier 1). B6 (pyridoxine) causes dose-dependent sensory peripheral neuropathy. The EFSA tolerable upper intake is 12 mg/day; neuropathy is documented even below 50 mg/day, and a case report describes it from a multivitamin containing just 6 mg/day. Many B-complex and "energy" products contain 25–100 mg of B6 — multiples of the safe ceiling. Australia's TGA (2023) and New Zealand's Medsafe (2023–2025) issued formal safety warnings. This is the rare case where the "water-soluble, so harmless" intuition is actively wrong, and it is under-publicised relative to the risk.

Mechanism

What B12 does and why absorption is the bottleneck. B12 (cobalamin) is a cofactor for DNA synthesis and myelin maintenance; deficiency produces megaloblastic anaemia and, if prolonged, irreversible neurological damage. To absorb food B12 you need (1) stomach acid and pepsin to free it from protein, then (2) intrinsic factor (made by gastric parietal cells) to ferry it across the ileum. Knock out either step — atrophic gastritis or acid suppression knocks out the first, autoimmune pernicious anaemia the second — and dietary B12 fails to reach the blood. This is why diet can't fix the common deficiencies.

Why supplements bypass the bottleneck. Crystalline B12 in a tablet is not protein-bound, so it does not need acid to be liberated. And about 1% of any oral dose is absorbed by passive diffusion, independent of intrinsic factor — which is why a high oral dose (250–1000 mcg) delivers enough usable B12 to correct even pernicious anaemia without an injection in many cases.

Why form is a non-issue orally. Cyanocobalamin is converted in the body to the active methyl- and adenosyl-cobalamin forms; the "you should take the pre-methylated form" pitch assumes a conversion bottleneck that does not limit repletion in practice. The clinical endpoints (serum B12, MMA normalisation, symptom resolution) are equivalent.

Why B6 damages nerves. Pyridoxine in excess is thought to overwhelm the conversion to its active coenzyme form and accumulate in dorsal root ganglia, producing a sensory neuropathy (numbness, tingling, gait unsteadiness). It is dose- and duration-dependent, and because it is sensory and insidious, people often keep taking the product through the early warning signs — at which point continued use risks permanent damage.

Risks And Contraindications

• B6 sensory neuropathy is the real hazard. Dose-dependent, can occur below 50 mg/day and has been reported as low as 6 mg/day in a susceptible case; EFSA upper limit is 12 mg/day. Symptoms (numbness, tingling, unsteadiness) warrant stopping immediately. The danger is hidden because B6 rides inside B-complex and "energy" blends marketed as harmless.
• B12 itself is low-risk: water-soluble, no established toxicity at the doses used for repletion. The risk is not from B12 but from (a) wasting money on a non-effect when not deficient, and (b) the B6 travelling with it in combination products.
• Don't self-treat suspected pernicious anaemia or neurological symptoms. Established neurological deficits need prompt clinical management; masking anaemia with high folate while B12 stays low can let nerve damage progress — get tested, don't guess.
• **Drug interactions are the cause, not a contraindication:** metformin and acid suppressants deplete B12; the answer is monitoring and repletion, not stopping a needed medication on your own.

Controversy

Nature: commercial, with overstatement at both poles.

Position A — "B vitamins are an energy/mood supplement everyone should take." The supplement-marketing take.
• Best evidence: in genuine deficiency, repletion resolves fatigue, glossitis, and early neurological signs — so the category has real clinical power.
• Where it's wrong: that power is confined to the deficient. In replete people, 16-RCT meta-analytic data and a dedicated fatigue RCT show no cognitive, mood, or fatigue benefit. "B12 for energy" sold to the mass market is selling a non-effect.

Position B — "Just eat liver and meat; B12 pills are a scam." The contrarian/food-purist take.
• Best evidence: a healthy young omnivore with normal stomach acid does get adequate B12 from food and needs no pill.
• Where it's wrong: it misdiagnoses the mechanism for the majority of deficient people. Atrophic gastritis, metformin, PPIs, and pernicious anaemia are absorption failures — more dietary B12 doesn't help when you can't liberate or transport it. For these groups the supplement (or injection) is the only thing that works.

The funding/bias dimension: supplement and "wellness/energy" brands profit by selling B12 and high-dose B-complex to the mass market as fatigue cures, and by charging a premium for "methylated/natural" forms — both claims unsupported for replete users. The contrarian "just eat meat" framing profits engagement but is wrong for the malabsorption-driven majority. The clean signal — NIH ODS / Food & Nutrition Board risk-group guidance, the Markun meta-analysis, the Tan fatigue RCT, the cyanocobalamin-vs-methylcobalamin reviews, and the EFSA/TGA/Medsafe B6 warnings — lands in the boring middle.

Realised Position: B12 is a genuine, sometimes urgent fix for defined risk groups, where the cause is usually malabsorption rather than diet — there, supplement (cyanocobalamin, cheap) or inject. For everyone else, "B vitamins for energy" is empty: test before treating fatigue, and don't pay for the non-effect. Buy cyanocobalamin, not premium methylcobalamin. And treat high-dose B6 in B-complexes as a real neurotoxicity hazard, not a harmless water-soluble bonus — keep it under 12 mg/day and never stack it.

Cross-Pillar Connections

• Diet (universal_nearuniversal_supplementation): that entry owns the general "is supplementing worth it" shortlist; this entry owns the specific B12 risk-group case and the B6 hazard. B12 makes the shortlist only for the gated groups.
• Diet (micronutrient_deficiency_screening): the test-before-treat logic — serum B12, MMA, holotranscobalamin — and the principle that supplementation should track a measured deficiency, not a symptom guess.
• Diet (supplement_form_elemental_dose_and_bioavailability): same label-literacy parent principle — the answer is in reading the actual dose (here, the B6 figure inside a B-complex), not the marketing.
• Diet (iron_supplementation_repletion_and_overload): a parallel "fatigue blamed on a single micronutrient" trap — both B12 and iron are commonly assumed energy fixes; both should be confirmed by labs, and both have a real downside if mishandled.
• Cross-pillar (fatigue_cross_pillar_diagnostic): fatigue has many causes (sleep, mental load, iron, thyroid, deconditioning); B12 is one branch and only worth pursuing once deficiency is plausible or measured.

What would change our mind

Falsifiability: explicit upgrade/downgrade criteria from source

• We'd broaden the "who benefits" gate if adequately-powered RCTs showed B12 or B-complex improving fatigue, cognition, or mood in clearly replete people — current best evidence (16 RCTs, the Tan fatigue trial) is null.
• We'd endorse paying for methylcobalamin if independent head-to-head trials showed it producing superior repletion or clinical outcomes versus cyanocobalamin at matched oral doses — solubility or theory wouldn't suffice.
• We'd soften the B6 caution if large pharmacovigilance and dosing studies showed no neuropathy risk at the 25–100 mg doses common in B-complexes — current EFSA limit (12 mg) and case/regulatory data point the other way.
• What would NOT move us: the malabsorption mechanism, the ~1% passive-diffusion absorption that makes high-dose oral work, or the risk-group list — these are settled physiology and consensus.

Industry bias note

Structural incentives the evidence base may reflect

This is a topic where the supplement industry profits at both ends, which is exactly why the consensus and independent data are the anchor.
• The mass-market end: "B12 for energy" and high-dose B-complexes are sold as fatigue cures to a replete public that gets no benefit — and the high-margin "methylated/natural" forms add a premium on top of an unsupported superiority claim.
• The contrarian end: "just eat liver/meat, pills are a scam" framing drives engagement but is wrong for the malabsorption-driven majority (atrophic gastritis, metformin, PPIs, pernicious anaemia) where diet cannot fix the problem.
• The hidden hazard: the "B-vitamins-are-harmless-water-soluble" assumption masks the genuine, under-publicised B6 neurotoxicity that brands have little incentive to highlight while selling 25–100 mg doses.
• The clean signal: NIH ODS / Food & Nutrition Board risk-group guidance, the Markun 2021 meta-analysis (null in the replete), the Tan fatigue RCT, the cyanocobalamin-equivalence reviews, and EFSA/TGA/Medsafe B6 warnings converge on the honest middle. Realised weights those over both the energy-supplement marketing and the food-purist counter-narrative.

B12 and B-Complex: Who Actually Needs It, and the B6 Trap